42 Technology boosts healthcare team with two additional consultants
Ian Cleathero and Steve Woodall will both actively contribute towards existing major projects, as well as helping identify new opportunities to develop novel medical devices, instrumentation and other products and processes for the fast-growing healthcare market.
Ian Cleathero (left) joins from Bespak Injectables, where he was technical director responsible for the development of several novel drug delivery devices including the world’s first commercial needle-free injector with electronic dosing. He has a background in injection moulding and design for manufacture; experience spanning medical devices, automotive, and consumer products; and is an appointed national expert on an ISO technical committee for medical device design. His earlier career included leading the polymers practice at European R&D consultancy Pera and engineering management roles in the automotive sector. Away from the office, Ian plays rugby for Melton Mowbray RFC Nomads and rides a Triumph Daytona 955 motorbike.
Steve Woodall (right) is a physicist and brings over 20 years’ experience in the development of advanced instrumentation and systems for use in pharmaceutical and diagnostics R&D laboratories. He spent six years with proteomics company NextGen Sciences leading the development team for a fully automated protein manufacturing system and covering all aspects of hardware and software development through to installation and customer training. He has also held product management and consulting roles with The Automation Partnership, Fisons Instruments and PA Technology. He started his industrial engineering career in defence electronics with Thorn EMI.
“Steve and Ian will significantly strengthen our dedicated in-house team and will be a real asset to many of our clients, not just in healthcare. They are both very skilled in running complex development projects, as well as being experts in combining novel science with sophisticated engineering which is essential in generating market-winners for the healthcare sector.”
Howard Biddle, managing director at 42 Technology.
42 Technology works with some of the world’s leading medical device, diagnostics and pharmaceutical companies to help design, develop and bring to market professional and consumer medical products.
Recent announcements include: working with FIND, the Geneva-based non-profit organisation on significantly improving the sensitivity of a new TB diagnostic and developing a novel arthroscopic toolset for biomedical company Tigenix. 42 Technology has also recently been awarded ISO 13485:2003 certification for the design and development of medical devices which enables faster regulatory compliance and is helping bring innovative new products to market at lower cost.